Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Lung Neuroendocrine Tumor G2 — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Endocrine Neoplasm
Neuroendocrine Neoplasm
Neuroendocrine Tumor
Neuroendocrine Tumor G2
Lung Neuroendocrine Tumor G2

Subtype

Lung Neuroendocrine Tumor G2

CI-CAN-00005820Explore in graph →

Non-malignant3 active trials

NCIt: C45551
OncoTree: ALUCA
UMLS CUI: C1708766

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials4
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Active Not Recruiting 2 Completed 1 Recruiting 1

PhaseAll Phase 1 1 Phase 2 2 Phase 3 1

No study matches these filters